- July 26, 2026
Drug Screening vs Laboratory Confirmation: What’s the Difference?
Learn the difference between rapid drug screening and laboratory confirmation, and understand when further analysis may be required.
Drug Screening vs Laboratory Confirmation: What’s the Difference?
Drug testing often involves two distinct stages: initial screening and laboratory confirmation. Although both stages analyse a specimen for evidence of drug use, they serve different purposes and should not be treated as interchangeable.
Understanding the difference is particularly important where the result may influence workplace, clinical, safeguarding or disciplinary decisions.
What is drug screening?
Drug screening is usually the first stage of the testing process. Its purpose is to identify samples that appear negative and those that may require further analysis.
Screening may be performed using:
- Urine drug testing cups
- Drug test dip cards
- Test cassettes
- Oral-fluid testing devices
- Laboratory-based immunoassay systems
[INTERNAL LINK: Link “urine drug testing cups” to the Virex Drug Cup product page.]
Point-of-care screening is commonly used because it can provide an initial result quickly and can be performed close to the collection location.
What does a screening result mean?
A screening result is generally reported as either negative or non-negative.
Negative result
A negative result means the target drug or metabolite was not detected at or above the screening test’s cut-off level.
This does not necessarily prove that no drug is present. A substance could be absent, present below the cut-off, outside the test’s detection period or not included in the selected drug panel.
Non-negative result
A non-negative result means the device has indicated that a target drug or metabolite may be present at or above the relevant cut-off level.
The term non-negative is important because an initial screen is preliminary. It does not automatically establish the exact substance present, prove misuse or determine impairment.
What is laboratory confirmation testing?
Laboratory confirmation is a separate analytical stage used to investigate a non-negative or disputed screening result.
Confirmatory testing usually combines a method that separates the components of a sample with mass-spectrometric identification. Methods can include:
- Gas chromatography–mass spectrometry, commonly written as GC-MS
- Liquid chromatography–mass spectrometry, including LC-MS or LC-MS/MS
Official technical guidance describes confirmatory analysis as using chromatographic separation combined with mass-spectrometric identification. SAMHSA
The purpose is to identify specific drugs or metabolites with greater analytical specificity than the original screening method.
[INTERNAL LINK: Link “Laboratory confirmation” to the Laboratory Confirmation Services page.]
Screening and confirmation serve different purposes
Screening
Screening is designed to:
- Provide an initial result
- Process samples quickly
- Identify specimens that appear negative
- Identify specimens that may need further investigation
Confirmation
Confirmation is designed to:
- Investigate an initial non-negative result
- Identify a specific drug or metabolite
- Use a separate and more specific analytical method
- Provide stronger analytical evidence where the result carries significant consequences
Initial immunoassays are useful for screening, but official guidance notes that they are not specific enough to serve as confirmatory tests. SAMHSA
Why may confirmation testing be necessary?
Confirmation may be required where:
- The screening result is disputed
- Disciplinary action may follow
- Employment or placement decisions may be affected
- Safeguarding concerns are involved
- A legally defensible process is required
- Organisational policy requires independent laboratory analysis
- A specific drug or metabolite must be identified
The UK’s clinical guidance on drug misuse states that when substantial weight or a significant decision will be based on a screening result, a laboratory confirmatory method should normally be used. GOV.UK
Does every screening test require confirmation?
Not necessarily.
Where a screening result is negative, the test has been performed correctly and there is no reason to challenge the result, further laboratory testing may not be required.
However, a non-negative result should be managed according to the organisation’s policy, the purpose of the test and the possible consequences for the person being tested. Where an important decision may follow, organisations should avoid treating a preliminary screen as though it were a confirmed laboratory finding.
What is the role of an accredited laboratory?
Accreditation provides independent assurance that a laboratory has been assessed against defined requirements for competence, impartiality and consistent operation.
In the UK, ISO/IEC 17025 is the internationally recognised standard commonly applied to testing laboratories. UKAS also publishes LAB 51, which explains how accreditation requirements apply to toxicology testing in specimens including urine, blood, hair and oral fluid. UKAS
[EXTERNAL LINK: Link “UKAS guidance on toxicology testing” to the UKAS LAB 51 information page.]
When selecting a confirmation provider, organisations should check that the laboratory’s accreditation schedule covers the relevant specimen, test method and intended purpose. UKAS explains that toxicology accreditation schedules identify the market sector or purpose of the analysis because different uses may have different technical and reporting requirements. UKAS
Why a clear workplace policy matters
A testing policy should explain:
- Why testing may take place
- Who may be tested
- Which specimen types and drug panels may be used
- How consent will be obtained
- How negative and non-negative results will be managed
- When laboratory confirmation will be arranged
- Who will receive the result
- How confidentiality and data protection will be maintained
- What support or disciplinary procedures may apply
The HSE advises that screening should not be treated as a complete response to workplace drug or alcohol misuse. Where testing is introduced, it should form part of the organisation’s wider health and safety policy. HSE
[EXTERNAL LINK: Link “HSE guidance on workplace screening and testing” to the HSE Screening and Testing page.]
Employers should also consider consent and fairness. GOV.UK states that employers require consent for workplace drug testing and should normally test only where there is a justified need. GOV.UK
[EXTERNAL LINK: Link “GOV.UK guidance on workplace drug testing” to the GOV.UK Drug Testing page.]
EWDTS workplace testing guidance
The European Workplace Drug Testing Society publishes guidance designed to support best-practice workplace drug testing. Its guidance resources cover urine, oral fluid, hair and exhaled breath. ewdts.org
[EXTERNAL LINK: Link “EWDTS workplace drug-testing guidelines” to the EWDTS Guidelines page.]
Final thoughts
Drug screening and laboratory confirmation are related, but they perform different roles.
Screening provides a rapid initial indication and helps identify specimens that may require further investigation. Laboratory confirmation uses a separate and more specific analytical method to investigate the result.
Organisations should ensure that the distinction is reflected in their policies, staff training and communications. A non-negative screening result should be managed carefully and, where appropriate, supported by independent laboratory confirmation before significant action is taken.
This article provides general information and does not replace product instructions, legal advice, occupational-health advice or an organisation’s own testing policy.
Popular Posts
Need support choosing a point-of-care drug test?
Contact Virex Diagnostics for guidance on urine drug testing cups, drug-panel options and professional testing requirements.